Revolution Medicines officer proposes $1.27M sale

The notice separately lists 6,000 shares from stock-option exercises and 309 shares from restricted stock units.

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) officer Alan Sandler reported a proposed sale of 6,309 common shares, with an approximate sale date of September 29, 2026, through Morgan Stanley Smith Barney LLC. The reported aggregate market value is $1,272,777.66. The notice also lists 341 common shares sold during the preceding three months, with an aggregate market value of $67,940.67.

Key Figures

Proposed sale: 6,309 common shares Aggregate market value: $1,272,777.66 Common shares outstanding: 214,336,418 shares +3 more

6 metrics

Proposed sale 6,309 common shares Approximate sale date September 29, 2026

Aggregate market value $1,272,777.66 Proposed sale

Common shares outstanding 214,336,418 shares September 29, 2026

Shares from stock-option exercise 6,000 shares September 29, 2026; cash payment

Shares from restricted stock units 309 shares September 15, 2026

Common shares sold during preceding three months 341 shares Aggregate market value $67,940.67

Key Terms

Rule 144, Exercise of Stock Options, Restricted Stock Units

3 terms

Rule 144 regulatory

"the definition of 'person' in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Stock Options financial

"Exercise of Stock Options"

Restricted Stock Units financial

"Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RVMD shares did Alan Sandler propose to sell?

Alan Sandler's notice lists a proposed sale of 6,309 common shares, with an approximate sale date of September 29, 2026, through Morgan Stanley Smith Barney LLC; the aggregate market value is $1,272,777.66.

How were the RVMD shares listed in Alan Sandler's notice acquired?

The notice lists 6,000 common shares from exercise of stock options on September 29, 2026, with cash payment, and 309 common shares from restricted stock units on September 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 04:25 PM Accepted by SEC EDGAR 09/29/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001835966
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REVOLUTION MEDICINES INC
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	ALAN SANDLER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6309	1272777.66	214336418	09/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/29/2026	Exercise of Stock Options	Issuer			6000	09/29/2026	Cash
Common	09/15/2026	Restricted Stock Units	Issuer			309	09/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ALAN SANDLER 700 Saginaw Drive Redwood City CA 94063	Common	09/16/2026	341	67940.67

144: Remarks and Signature

Remarks
Date of Notice	09/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Alan Sandler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)